↓ Skip to main content

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

Overview of attention for article published in The Lancet, March 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Citations

dimensions_citation
137 Dimensions

Readers on

mendeley
120 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
Published in
The Lancet, March 2012
DOI 10.1016/s0140-6736(11)61619-x
Pubmed ID
Authors

Neil E Fleshner, M Scott Lucia, Blair Egerdie, Lorne Aaron, Gregg Eure, Indrani Nandy, Libby Black, Roger S Rittmaster

Abstract

We aimed to investigate the safety and efficacy of dutasteride, a 5α-reductase inhibitor, on prostate cancer progression in men with low-risk disease who chose to be followed up with active surveillance.

Twitter Demographics

The data shown below were collected from the profiles of 32 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 4 3%
United States 2 2%
United Kingdom 2 2%
Netherlands 1 <1%
Canada 1 <1%
Slovenia 1 <1%
Denmark 1 <1%
Colombia 1 <1%
Unknown 107 89%

Demographic breakdown

Readers by professional status Count As %
Researcher 25 21%
Student > Doctoral Student 14 12%
Student > Postgraduate 13 11%
Student > Ph. D. Student 13 11%
Other 10 8%
Other 36 30%
Unknown 9 8%
Readers by discipline Count As %
Medicine and Dentistry 73 61%
Agricultural and Biological Sciences 10 8%
Biochemistry, Genetics and Molecular Biology 3 3%
Mathematics 3 3%
Psychology 3 3%
Other 11 9%
Unknown 17 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 47. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2019.
All research outputs
#452,418
of 15,390,521 outputs
Outputs from The Lancet
#4,691
of 34,669 outputs
Outputs of similar age
#4,052
of 218,316 outputs
Outputs of similar age from The Lancet
#63
of 528 outputs
Altmetric has tracked 15,390,521 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 34,669 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.5. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 218,316 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 528 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.